XML 21 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover - shares
 12 Months Ended
Mar. 31, 2022
Jul. 21, 2022
Entity Addresses [Line Items]    
Document Type 20-F  
Amendment Flag false  
Document Registration Statement false  
Document Annual Report true  
Document Transition Report false  
Document Shell Company Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --03-31  
Entity File Number 001-41386  
Entity Registrant Name OKYO Pharma Limited  
Entity Central Index Key 0001849296  
Entity Incorporation, State or Country Code Y7  
Entity Address, Address Line One Martello Court  
Entity Address, Address Line Two Admiral Park  
Entity Address, City or Town St. Peter Port  
Entity Address, Country GG  
Entity Address, Postal Zip Code GY1  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers Yes  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Document Accounting Standard International Financial Reporting Standards  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,374,415,468
Auditor Firm ID 1401  
Auditor Name Mazars LLP  
Auditor Location London, England  
Business Contact [Member]    
Entity Addresses [Line Items]    
Entity Address, Address Line One 107 Cheapside  
Entity Address, City or Town London  
Entity Address, Country GB  
Entity Address, Postal Zip Code EC2V 6DN  
City Area Code +44  
Local Phone Number 20 7495 2379  
Contact Personnel Name Chief Financial Officer